Pharmacokinetic and pharmacodynamic analysis of fluorouracil in nasopharyngeal cancer patients.

e13021 Background: Pharmacokinetic (PK) variability of 5-FU has been demonstrated for +30 years and a significant link between 5-FU exposure and therapeutic response has been identified. A maximum ...